JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaw, L. J.
Right arrow Articles by Berman, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaw, L. J.
Right arrow Articles by Berman, D. S.
Journal of Nuclear Medicine Vol. 42 No. 9 1424-1436
© 2001 by Society of Nuclear Medicine


SPECIAL CONTRIBUTION

Evidence-Based Risk Assessment in Noninvasive Imaging

Leslee J. Shaw, Ami E. Iskandrian, Rory Hachamovitch, Guido Germano, Howard C. Lewin, Timothy M. Bateman and Daniel S. Berman

Emory University, Atlanta, Georgia; University of Alabama—Birmingham, Birmingham, Alabama; Cedars-Sinai Medical Center, Los Angeles, California; Cornell Medical Center—The New York Hospital, New York, New York; and Cardiovascular Consultants PC, Kansas, Missouri

Assessment of important clinical and economic outcomes has become central to the evaluation of patient care. Outcome research is deeply rooted in epidemiology, including the use of multivariable, risk-adjusted regression analysis. In our current health care environment, these methods are increasingly being used to assess the quality of care and to profile physicians and laboratories. Nuclear medicine physicians therefore need to better understand outcome methodologies in order to evaluate patient outcomes, develop guidelines, and decide on patient management. Methods: This review describes the methods of assessing the diagnostic and prognostic value of nuclear medicine techniques and, briefly, the methodologic limitations of sample size, frequency and type of events, and follow-up periods and the incremental value of imaging. Also described are logistic regression and Cox proportional hazards modeling. Models for risk assessment are designed to identify whether patients require conservative (i.e., low-risk) or aggressive (i.e., high-risk) treatment. Treatment selection is currently based on risk assessment and the formation of an integrated, empiric risk stratification algorithm of care. This review also includes the methods of assessing economic effectiveness and quality-of-life issues for patients examined with nuclear medicine techniques. Conclusion: In this era of constrained resources, low-cost outpatient-based care may be of increasing importance. High-quality evidence of the clinical and economic outcome of nuclear imaging is essential for helping health care providers and payers assess its value.

Key Words: prognosis outcomes • cost-effectiveness • quality of life • risk stratification




This article has been cited by other articles:


Home page
BMJHome page
S. K Prasad, R. G Assomull, and D. J Pennell
Recent developments in non-invasive cardiology
BMJ, December 11, 2004; 329(7479): 1386 - 1389.
[Full Text] [PDF]


Home page
JNMHome page
R. C. Marshall, P. Powers-Risius, B. W. Reutter, J. P. O'Neil, M. La Belle, R. H. Huesman, and H. F. VanBrocklin
Kinetic Analysis of 18F-Fluorodihydrorotenone as a Deposited Myocardial Flow Tracer: Comparison to 201Tl
J. Nucl. Med., November 1, 2004; 45(11): 1950 - 1959.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.